Literature DB >> 26254839

Antenatal Magnesium and Cerebral Palsy in Preterm Infants.

Deborah G Hirtz1, Steven J Weiner2, Dorothy Bulas3, Michael DiPietro4, Joanna Seibert5, Dwight J Rouse6, Brian M Mercer7, Michael W Varner8, Uma M Reddy9, Jay D Iams10, Ronald J Wapner11, Yoram Sorokin12, John M Thorp13, Susan M Ramin14, Fergal D Malone15, Marshall W Carpenter16, Mary J O'Sullivan17, Alan M Peaceman18, Gary D V Hankins19, Donald Dudley20, Steve N Caritis21.   

Abstract

OBJECTIVE: To evaluate the relationship of maternal antenatal magnesium sulfate (MgSO4) with neonatal cranial ultrasound abnormalities and cerebral palsy (CP). STUDY
DESIGN: In a randomized trial of MgSO4 or placebo in women at high risk of preterm delivery, up to 3 cranial ultrasounds were obtained in the neonatal period. Images were reviewed by at least 2 pediatric radiologists masked to treatment and other clinical conditions. Diagnoses were predefined for intraventricular hemorrhage, periventricular leukomalacia, intracerebral echolucency or echodensity, and ventriculomegaly. CP was diagnosed at 2 years of age by standardized neurologic examination.
RESULTS: Intraventricular hemorrhage, periventricular leukomalacia, intracerebral echolucency or echodensity, and ventriculomegaly were all strongly associated with an increased risk of CP. MgSO4 administration did not affect the risk of cranial ultrasound abnormality observed at 35 weeks postmenstrual age or later. However, for the 82% of infants born at <32 weeks gestation, MgSO4 was associated with a reduction in risk of echolucency or echodensity. The reduction in risk for echolucency explained 21% of the effect of MgSO4 on CP (P = .04), and for echodensity explained 20% of the effect (P = .02).
CONCLUSIONS: MgSO4 given prior to preterm delivery was associated with decreased risk of developing echodensities and echolucencies at <32 weeks gestation. However, this effect can only partially explain the effect of MgSO4 on CP at 2 years of age. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00014989. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26254839      PMCID: PMC4587284          DOI: 10.1016/j.jpeds.2015.06.067

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  36 in total

1.  Transient periventricular echodensities in preterms and neurodevelopmental outcome.

Authors:  Francesco Pisani; Luisa Leali; Sabrina Moretti; Emanuela Turco; Enrico Volante; Giulio Bevilacqua
Journal:  J Child Neurol       Date:  2006-03       Impact factor: 1.987

2.  Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997.

Authors:  Kaija Mikkola; Niina Ritari; Viena Tommiska; Teija Salokorpi; Liisa Lehtonen; Outi Tammela; Leena Pääkkönen; Päivi Olsen; Marit Korkman; Vineta Fellman
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

3.  Trends in cerebral palsy among infants of very low birthweight (<1500 g) or born prematurely (<32 weeks) in 16 European centres: a database study.

Authors:  Mary Jane Platt; Christine Cans; Ann Johnson; Geraldine Surman; Monica Topp; Maria Giulia Torrioli; Inge Krageloh-Mann
Journal:  Lancet       Date:  2007-01-06       Impact factor: 79.321

Review 4.  Outcome following preterm birth.

Authors:  Alan T Gibson
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2007-05-25       Impact factor: 5.237

5.  Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage.

Authors:  J C Canterino; U L Verma; P F Visintainer; R Figueroa; S A Klein; N A Tejani
Journal:  Obstet Gynecol       Date:  1999-03       Impact factor: 7.661

6.  The effect of maternal magnesium sulfate treatment on neonatal morbidity in < or = 1000-gram infants.

Authors:  D F Kimberlin; J C Hauth; R L Goldenberg; S F Bottoms; J D Iams; B Mercer; C MacPherson; G R Thurnau
Journal:  Am J Perinatol       Date:  1998       Impact factor: 1.862

7.  Adverse neurodevelopmental outcomes among extremely low birth weight infants with a normal head ultrasound: prevalence and antecedents.

Authors:  Abbot R Laptook; T Michael O'Shea; Seetha Shankaran; Brinda Bhaskar
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

8.  [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].

Authors:  S Marret; L Marpeau; C Follet-Bouhamed; G Cambonie; D Astruc; B Delaporte; H Bruel; B Guillois; D Pinquier; V Zupan-Simunek; J Bénichou
Journal:  Gynecol Obstet Fertil       Date:  2008-03-11

9.  Antenatal magnesium sulphate neuroprotection in the preterm infant.

Authors:  Stéphane Marret; Lex W Doyle; Caroline A Crowther; Philippa Middleton
Journal:  Semin Fetal Neonatal Med       Date:  2007-05-21       Impact factor: 3.926

10.  The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth.

Authors:  N S Wood; K Costeloe; A T Gibson; E M Hennessy; N Marlow; A R Wilkinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

View more
  9 in total

1.  Magnesium induces preconditioning of the neonatal brain via profound mitochondrial protection.

Authors:  Gabriella Koning; Anna-Lena Leverin; Syam Nair; Leslie Schwendimann; Joakim Ek; Ylva Carlsson; Pierre Gressens; Claire Thornton; Xiaoyang Wang; Carina Mallard; Henrik Hagberg
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-05       Impact factor: 6.200

2.  The effect of antenatal magnesium sulfate on intraventricular hemorrhage in premature infants: a systematic review and meta-analysis.

Authors:  Yousef Moradi; Rozhin Khateri; Ladan Haghighi; Shoaib Dehghani; Shiva Mansouri Hanis; Mehrdad Valipour; Zahra Najmi; Zahra Fathollahy; Meisam Allahmoradi; Kamyar Mansori
Journal:  Obstet Gynecol Sci       Date:  2020-06-24

3.  Antenatal Exposure to Magnesium Sulfate Is Associated with Reduced Cerebellar Hemorrhage in Preterm Newborns.

Authors:  Dawn Gano; Mai-Lan Ho; John Colin Partridge; Hannah C Glass; Duan Xu; A James Barkovich; Donna M Ferriero
Journal:  J Pediatr       Date:  2016-07-22       Impact factor: 4.406

4.  Neonatal Magnesium Levels Between 24 and 48 Hours of Life and Outcomes for Epilepsy and Motor Impairment in Premature Infants.

Authors:  Betsy Ostrander; Tyler Bardsley; Ernest Kent Korgenski; Tom Greene; Joshua L Bonkowsky
Journal:  Pediatr Neurol       Date:  2016-03-03       Impact factor: 3.372

5.  Antenatal Betamethasone: A Prolonged Time Interval from Administration to Delivery Is Associated with an Increased Incidence of Severe Intraventricular Hemorrhage in Infants Born before 28 Weeks Gestation.

Authors:  Melissa Liebowitz; Ronald I Clyman
Journal:  J Pediatr       Date:  2016-08-08       Impact factor: 4.406

6.  A Model of Germinal Matrix Hemorrhage in Preterm Rat Pups.

Authors:  Masako Jinnai; Gabriella Koning; Gagandeep Singh-Mallah; Andrea Jonsdotter; Anna-Lena Leverin; Pernilla Svedin; Syam Nair; Satoru Takeda; Xiaoyang Wang; Carina Mallard; Carl Joakim Ek; Eridan Rocha-Ferreira; Henrik Hagberg
Journal:  Front Cell Neurosci       Date:  2020-12-03       Impact factor: 5.505

Review 7.  Perinatal neuroprotection update.

Authors:  Angie C Jelin; Kirsten Salmeen; Dawn Gano; Irina Burd; Mari-Paule Thiet
Journal:  F1000Res       Date:  2016-08-09

8.  In Premature Newborns Intraventricular Hemorrhage Causes Cerebral Vasospasm and Associated Neurodisability via Heme-Induced Inflammasome-Mediated Interleukin-1 Production and Nitric Oxide Depletion.

Authors:  Michael Eisenhut; Samyami Choudhury
Journal:  Front Neurol       Date:  2017-08-18       Impact factor: 4.003

Review 9.  Fetal Neuroprotection by Magnesium Sulfate: From Translational Research to Clinical Application.

Authors:  Clément Chollat; Loïc Sentilhes; Stéphane Marret
Journal:  Front Neurol       Date:  2018-04-16       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.